Perspectives

 
 

  • Sep 08 2023 This Week in Cardiology   ESC Recap Part 2: ECLS-SHOCK, FIRE, MULTISTARS-AMI, HEART FID, and DANPACE II are the trials John Mandrola, MD, discusses in this week’s podcast.
  • Heart Failure Guidelines Update: What the ESC Got Right   Heart failure specialist Dr Ileana Piña discusses what she likes about the 2023 ESC focused update to the heart failure guidelines.
  • Is AF Ablation the Fifth Pillar in Heart Failure Care?   John Mandrola interviews CASTLE-Htx investigators, Christian Sohns, and Philipp Sommer about the role of ablation in patients with AF and end stage heart failure.
  • Is Complete Revascularization Now Compulsory?   Michelle O'Donoghue and interventional cardiologist Sahil Parikh discuss data presented at ESC on benefits for complete revascularization in both STEMI and NSTEMI that also extend to older patients.
  • Pediatrics e-Tumor Boards: Case 2: Advanced Stage Recurrent Cervical Cancer   This is a case of a 75-year-old woman with recurrent squamous cell carcinoma of the cervix. She initially presented with postmenopausal bleeding. The team debates treatment plans of chemotherapy, radiation, or surgery.
  • Pediatrics e-Tumor Boards: Case 1: Cervical Adenosquamous Carcinoma   This case involves a 29-year-old woman presenting with post-coital bleeding and diagnosed with cervical adenosquamous carcinoma. The team discusses the importance of fertility preserving tactics, surveillance, and chemotherapy in conjunction with radiation therapy.
  • Blood Test for Severe Preeclampsia Will Save Lives The Food and Drug Administration recently approved a blood test that will predict, with 96% accuracy, whether a pregnant person will develop severe preeclampsia within 2 weeks.
  • 20 Best Places for Doctors to Retire: 2023 Where would you like to retire? Find out which places have the "secret sauce."
  • Left-Digit Bias and Other Random Acts of Medicine   A new book reveals how chance can change the course of a person's health, life, and death.
  • Change Makers: Elcin Barker Ergun on Healthcare Renaissance WebMD Chief Medical Officer John Whyte, MD, MPH, speaks with Elcin Barker Ergun, CEO of the Menarini Group, in Florence, Italy, about what they believe to be a new renaissance in healthcare.
  • Episode 6: RSV in Rural Communities: Lessons From Appalachia   Rates of RSV are rising in rural communities. How are rural healthcare providers responding? Join Drs Forest Arnold and Brittanie West as they discuss.
  • S2 Episode 6: Neoadjuvant Therapy and Renal Cell Carcinoma   Drs Sumanta Pal and Jose A. Karam discuss neoadjuvant therapy in renal cell carcinoma, including TKIs, IO, and the need for more studies to explore the role of neoadjuvant therapy in RCC.
  • Episode 10: Approach to Cardiotoxicity: Art That Needs More Science   Drs Michelle Kittleson and Bonnie Ky discuss the field of cardio-oncology and how cancer treatment-related cardiotoxicity can be prevented, detected, and treated to improve the quality of cancer survivorship.
  • The Magic of Music Music can transport you to another place, briefly clearing your head from what is going on around you. It is a welcome escape to a virtual beach and tropical drink.
  • How to Interpret a Urine Drug Test   Addiction medicine physicians discuss the different types of urine drug tests, false positives, invalid tests, and how to communicate results to patients.
  • Journal Summary: Vitiligo Journal Summaries provide a quick review of recent journal articles with current or near-term clinical significance. Catch up on key research on vitiligo from the past year.
  • Medscape Hospitalist Wealth & Debt Report 2023 Hospitalists report their successes and failures in building wealth, controlling spending, managing debt and expenses, investing smartly, and maintaining a comfortable lifestyle.
  • Do You P.U.I.? In case you are looking for a place to park your discretionary funds, I have recently learned that nonalcoholic beer is the fastest-growing segment of the beer industry.
  • Episode 3: How Do You Optimize Neoadjuvant Therapy Selection?   Join experts Drs Kevin Kalinsky and Priyanka Sharma as they discuss their current approach to neoadjuvant therapy in triple-negative breast cancer and how the SCARLET trial might change that.
  • The New Normal in Body Temperature   Are humans more cold-blooded than we have always believed? F. Perry Wilson reviews a study of "normal" oral temperatures in adults.